Zimmer Biomet Holdings, Inc.ZBHNYSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank50
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P50
Within normal range
vs 2Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
20254.82%
2024-4.64%
202312.98%
2022-6.84%
202135.01%
2020-28.15%
201914.71%
20185.89%
20171.18%
201636.01%